相关实验视频
Updated: Jul 22, 2025

08:42
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
4.5K
PLS3在骨质稳定和疾病中的复杂机制
Wenchao Zhong1,2,3,4, Janak L Pathak4, Yueting Liang5,6
1Department of Human Genetics, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Frontiers in endocrinology
|July 24, 2023
概括
在PLS3基因的遗传缺陷导致骨脆弱,导致骨质疏松症和骨关节炎. 本综述探讨了PLS3在骨细胞中的功能,以了解疾病机制并开发治疗方法.
科学领域:
- 骨生物学 骨生物学
- 遗传学 遗传学 是一个
- 细胞机制 细胞机制
背景情况:
- 在2013年发现的Plastin 3 (PLS3) 的遗传缺陷与骨脆弱性有关.
- PLS3变种与综合征/非综合征性骨质疏松症和骨关节炎有关.
- 尽管PLS3突变具有广泛的表达模式,但导致骨病的确切机制仍然不清楚.
研究的目的:
- 审查目前对PLS3功能在关键骨细胞:骨细胞,骨质细胞和骨质细胞的理解.
- 阐明PLS3在骨病理学中的作用,包括机械传导,调节,囊泡贩运,细胞分化和矿化.
- 突出需要进一步研究PLS3在骨疾病中的机制,以开发治疗方法.
主要方法:
- 对骨细胞中PLS3功能现有研究的文献综述.
- 分析PLS3在骨代谢相关的细胞过程中的作用.
- 综合有关PLS3相关骨病理的当前知识.
主要成果:
- 在骨细胞中,PLS3对于调节机械转导,平衡和囊泡运输至关重要.
- 在PLS3中存在的缺陷会影响骨质细胞的分化和矿化,导致骨质的质量下降.
- PLS3 功能障碍会影响骨质细胞活性,可能导致骨质再吸收增加.
结论:
- 通过影响各种细胞功能,PLS3在维持骨健康方面发挥着多方面的作用.
- 了解PLS3在骨细胞中的机制对于开发针对骨质疏松症和相关骨疾病的向治疗非常重要.
- 进一步研究PLS3的分子通路是有必要的,以解决与其缺陷相关的复杂骨病理.
相关概念视频
Bone Remodeling
38.4K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.4K
Bone Disorders
3.7K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.7K
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
What is the Skeletal System?
52.9K
Overview
52.9K
Hormones and Bone Tissue
2.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.7K
Skeleton and Calcium Homeostasis
4.6K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
4.6K

